Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

Alzheimer’s dementia (AD) and frontotemporal dementias (FTD) are common and their clinical differential diagnosis may be complicated by overlapping symptoms, which is why biomarkers may have an important role to play. Cerebrospinal fluids (CSF) Aβ2-42 and 1-42 have been shown to be similarly decreas...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibl, Mirko, Gallus, Marion, Welge, Volker, Esselmann, Hermann, Wolf, Stefanie, Rüther, Eckart, Wiltfang, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2012
Materias:
Dementias - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605494/
https://www.ncbi.nlm.nih.gov/pubmed/22527776
http://dx.doi.org/10.1007/s00702-012-0801-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605494/
https://www.ncbi.nlm.nih.gov/pubmed/22527776
http://dx.doi.org/10.1007/s00702-012-0801-3

Ejemplares similares